Compile Data Set for Download or QSAR
Report error Found 12 of affinity data for UniProtKB/TrEMBL: Q9ERK9
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50608213BDBM50608213(CHEMBL5274126)
Affinity DataEC50:  1nMAssay Description:Agonist activity at P2Y6R in mouse adipose tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50569551BDBM50569551(CHEMBL4877977)
Affinity DataIC50: 4.94E+3nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50405434BDBM50405434(CHEMBL5274312)
Affinity DataIC50: 6.15E+3nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50405436BDBM50405436(CHEMBL5286996)
Affinity DataIC50: 1.45E+4nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50405432BDBM50405432(CHEMBL5277295)
Affinity DataIC50: 1.52E+4nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50405433BDBM50405433(CHEMBL5283029)
Affinity DataIC50: 1.76E+4nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50405435BDBM50405435(CHEMBL5280754)
Affinity DataIC50: 1.78E+4nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50569547BDBM50569547(CHEMBL4854398)
Affinity DataIC50: 2.02E+4nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50569548BDBM50569548(CHEMBL4875858)
Affinity DataIC50: 2.87E+4nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50405421BDBM50405421(CHEMBL5279730)
Affinity DataIC50: 3.08E+4nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50405423BDBM50405423(CHEMBL5283362)
Affinity DataIC50: 3.16E+4nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50569546BDBM50569546(CHEMBL4876210)
Affinity DataIC50: 1.85E+5nMAssay Description:Antagonist activity at mouse P2Y6R expressed in human 1321N1 cells assessed as inhibition of UDP-induced calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed